TRIM29 and squamous cell carcinoma: In the A431 human squamous carcinoma cell line, ATDC was noted to interact with the intermediate-filament protein vimentin and with an inhibitor of protein kinase C, thereby acting as a component of the protein kinase C signal transduction pathway [29].